EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review)

Xianfei Zhou, Chongjun Yang, Zhiyong Weng, Lihua Li

International Journal of Molecular Medicine · 21.10.2026 · 58 (6) · 1-22

DOI: 10.3892/ijmm.2026.6020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 21.10.2026. Verfasst von Xianfei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou Unive…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Transcription Factors, Nanotechnology. Die Arbeit nennt 173 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, a common pathological outcome of chronic liver diseases, is a dynamic process characterized by molecular and cell interactions. Transcription factors (TFs) are key in modulating gene expression programs that govern hepatocyte fate, metabolic homeostasis, inflammation and extracellular matrix remodeling. In hepatocytes, TFs such as hepatocyte nuclear factor 4α and FOXA2 serve a key role in maintaining metabolic balance, with their dysfunction leading to lipid accumulation, oxidative stress and profibrotic signaling. In non‑parenchymal cells, including hepatic stellate, Kupffer and liver sinusoidal and biliary epithelial cells, TFs such as YAP/TAZ, NF‑κB, STAT3 and GATA‑binding factor 4 regulate activation, proliferation and intercellular communication, thereby influencing fibrosis progression or resolution. Advances in single‑cell omics, spatial transcriptomics and epigenomics are elucidating the dynamic, cell type‑specific TF networks involved in fibrosis and identifying therapeutic targets. Nanotechnology presents strategies for precise modulation of TFs and selective targeting of hepatic cell populations, facilitated by nanocarriers that enable the delivery of nucleic acids, pathway inhibitors and epigenetic modulators. Preclinical studies indicate promising antifibrotic effects of nanodelivery systems, however, challenges related to biocompatibility, targeting efficiency and clinical translation persist. This review aimed to summarize TF‑mediated regulation in liver fibrosis and nanotechnology‑based therapeutic approaches as well as future directions for precision antifibrotic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisTranscription FactorsNanotechnologyHumansAnimalsGene Expression Regulation

Stichwörter der Autor:innen

epigenetic regulationinflammationliver fibrosisnanotherapeutictranscription factors

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318001, P.R. China.
  • Department of Pathophysiology, School of Basic Medicine, Shenyang Medical College, Shenyang, Liaoning 110000, P.R. China.
  • School of Art and Design, Taizhou University, Taizhou, Zhejiang 318001, P.R. China.
  • Department of Basic Medicine and Medical Laboratory Science, School of Medicine, Taizhou University, Taizhou, Zhejiang 318001, P.R. China.

Zitieren

APA

Zhou, X., Yang, C., Weng, Z., & Li, L. (2026). Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review). International Journal of Molecular Medicine, 58(6), 1-22. https://doi.org/10.3892/ijmm.2026.6020

Vancouver

Zhou X, Yang C, Weng Z, Li L. Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review). International Journal of Molecular Medicine. 2026;58(6):1-22. doi:10.3892/ijmm.2026.6020

BibTeX
@article{Zhou2026,
  author = {Zhou, Xianfei and Yang, Chongjun and Weng, Zhiyong and Li, Lihua},
  title = {Transcription factors in liver fibrosis: Mechanistic insights and nanotechnology‑driven therapeutic strategies (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {1--22},
  doi = {10.3892/ijmm.2026.6020}
}
Kostenlos starten →